Education
About Us
Working with TipRanks
Follow Us
Atai Life Sciences N.V. (ATAI)
:ATAI
Total Valuation
ATAI Life Sciences has a market cap or net worth of $831.63M. The enterprise value is $343.93M.
Market Cap$831.63M
Enterprise Value$343.93M
Share Statistics
ATAI Life Sciences has 214,338,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding214,338,330
Owned by Insiders33.08%
Owned by Institutions5.75%
Financial Efficiency
ATAI Life Sciences’s return on equity (ROE) is -1.28 and return on invested capital (ROIC) is -71.01%.
Return on Equity (ROE)-1.28
Return on Assets (ROA)-0.94
Return on Invested Capital (ROIC)-71.01%
Return on Capital Employed (ROCE)-0.76
Revenue Per Employee5.70K
Profits Per Employee-2.78M
Employee Count54
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ATAI Life Sciences is ―. ATAI Life Sciences’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value1.83
Price to FCF0.00
Price to Operating Cash Flow-7.55
PEG Ratio―
Income Statement
In the last 12 months, ATAI Life Sciences had revenue of 308.00K and earned -149.27M in profits. Earnings per share was -0.93.
Revenue308.00K
Gross Profit1.55M
Operating Income-102.69M
Pretax Income-148.41M
Net Income-149.27M
EBITDA-145.33M
Earnings Per Share (EPS)-0.93
Cash Flow
In the last 12 months, operating cash flow was -3.89M and capital expenditures -5.00K, giving a free cash flow of -3.89M billion.
Operating Cash Flow-3.89M
Free Cash Flow-3.89M
Free Cash Flow per Share-0.02
Dividends & Yields
ATAI Life Sciences pays an annual dividend of $6, resulting in a dividend yield of ―
Dividend Per Share$6
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.40
52-Week Price Change196.18%
50-Day Moving Average3.03
200-Day Moving Average1.94
Relative Strength Index (RSI)57.64
Average Volume (3m)6.43M
Important Dates
ATAI Life Sciences upcoming earnings date is Nov 18, 2025, Before Open (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend DateAug 27, 2018
Financial Position
ATAI Life Sciences as a current ratio of 3.21, with Debt / Equity ratio of 9.37%
Current Ratio3.21
Quick Ratio3.21
Debt to Market Cap0.11
Net Debt to EBITDA-0.05
Interest Coverage Ratio-32.87
Taxes
In the past 12 months, ATAI Life Sciences has paid -356.00K in taxes.
Income Tax-356.00K
Effective Tax Rate<0.01
Enterprise Valuation
ATAI Life Sciences EV to EBITDA ratio is -1.52, with an EV/FCF ratio of -2.67.
EV to Sales714.98
EV to EBITDA-1.52
EV to Free Cash Flow-2.67
EV to Operating Cash Flow-2.67
Balance Sheet
ATAI Life Sciences has $98.20M in cash and marketable securities with $26.67M in debt, giving a net cash position of -$71.54M billion.
Cash & Marketable Securities$98.20M
Total Debt$26.67M
Net Cash-$71.54M
Net Cash Per Share-$0.33
Tangible Book Value Per Share$0.71
Margins
Gross margin is 87.92%, with operating margin of -33341.23%, and net profit margin of -48463.96%.
Gross Margin87.92%
Operating Margin-33341.23%
Pretax Margin-48183.44%
Net Profit Margin-48463.96%
EBITDA Margin-47186.04%
EBIT Margin-47169.16%
Analyst Forecast
The average price target for ATAI Life Sciences is $10.31, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$10.31
Price Target Upside165.72% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast-0.90%
EPS Growth Forecast-89.51%